- Report
- April 2025
- 200 Pages
Global
From €3966EUR$4,490USD£3,475GBP
- Report
- October 2025
- 160 Pages
Global
From €2966EUR$3,358USD£2,599GBP
€3489EUR$3,950USD£3,057GBP
- Report
- January 2025
- 429 Pages
Global
From €4373EUR$4,950USD£3,831GBP
- Report
- August 2025
- 149 Pages
Global
From €2252EUR$2,549USD£1,973GBP
€2649EUR$2,999USD£2,321GBP
- Report
- August 2025
- 198 Pages
Global
From €3132EUR$3,545USD£2,744GBP
€3480EUR$3,939USD£3,049GBP
- Report
- December 2025
- 268 Pages
Global
From €5168EUR$5,850USD£4,528GBP
- Report
- December 2025
- 189 Pages
Global
From €5168EUR$5,850USD£4,528GBP
- Report
- December 2025
- 351 Pages
Global
From €5168EUR$5,850USD£4,528GBP
- Report
- April 2025
- 250 Pages
Global
From €3966EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3966EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3966EUR$4,490USD£3,475GBP
- Report
- June 2025
- 400 Pages
Global
From €4372EUR$4,949USD£3,830GBP
- Report
- October 2025
- 160 Pages
Global
From €2966EUR$3,358USD£2,599GBP
€3489EUR$3,950USD£3,057GBP
- Report
- March 2025
- 86 Pages
Global
From €3500EUR$4,244USD£3,174GBP
- Report
- September 2025
- 140 Pages
Global
From €3642EUR$4,123USD£3,191GBP
€4284EUR$4,850USD£3,754GBP
- Report
- April 2025
- 225 Pages
Global
From €3975EUR$4,500USD£3,483GBP
- Report
- March 2025
- 140 Pages
Global
From €3642EUR$4,123USD£3,191GBP
€4284EUR$4,850USD£3,754GBP
- Report
- June 2025
- 100 Pages
United States
From €3092EUR$3,500USD£2,709GBP
- Report
- May 2024
- 298 Pages
Global
From €4373EUR$4,950USD£3,831GBP
- Report
- November 2024
- 165 Pages
Global
From €5256EUR$5,950USD£4,605GBP

The External Pacemakers market is a segment of the Cardiovascular Devices industry. It consists of devices that are used to regulate the heart rate of patients with arrhythmia, a condition in which the heart beats too fast, too slow, or irregularly. These devices are typically implanted under the skin and deliver electrical pulses to the heart to regulate its rhythm. External pacemakers are used in cases where the patient cannot tolerate an implantable device, or when the patient's condition is not severe enough to require an implantable device.
External pacemakers are typically used in the treatment of bradycardia, a condition in which the heart rate is too slow, and tachycardia, a condition in which the heart rate is too fast. They are also used to treat atrial fibrillation, a condition in which the heart beats irregularly.
Some of the companies in the External Pacemakers market include Medtronic, St. Jude Medical, Biotronik, Boston Scientific, and Sorin Group. Show Less Read more